Zimmer Biomet Holdings, Inc. (ZBH) stock
ZBHNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3018% below fair value
$103.32+1.23 (+1.20%)
Close on Nov 18, 2026Market cap $19.71BP/E 25.1Yield 0.93%
Zimmer Biomet operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Zimmer Biomet's operating cash flow for the twelve months ending Jun 30, 2026 was $1.74B, up 4.8% year over year. For fiscal 2025 it was $1.70B, up 13.2% from the year before. Over ten years it grew 7.2% a year on average. The highest annual figure on record is $1.75B in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.70B | +13.2% |
| FY2024 | Dec 31, 2024 | $1.50B | -5.2% |
| FY2023 | Dec 31, 2023 | $1.58B | +16.6% |
| FY2022 | Dec 31, 2022 | $1.36B | -3.4% |
| FY2021 | Dec 31, 2021 | $1.40B | +30.6% |
| FY2020 | Dec 31, 2020 | $1.08B | -32.2% |
| FY2019 | Dec 31, 2019 | $1.59B | -9.2% |
| FY2018 | Dec 31, 2018 | $1.75B | +10.4% |
| FY2017 | Dec 31, 2017 | $1.58B | -3.1% |
| FY2016 | Dec 31, 2016 | $1.63B | +92.1% |
| FY2015 | Dec 31, 2015 | $849.80M | -19.9% |
| FY2014 | Dec 31, 2014 | $1.06B | +10.1% |
| FY2013 | Dec 31, 2013 | $963.10M | -16.4% |
| FY2012 | Dec 31, 2012 | $1.15B | -2.1% |
| FY2011 | Dec 31, 2011 | $1.18B | -1.4% |
| FY2010 | Dec 31, 2010 | $1.19B | +6.8% |
| FY2009 | Dec 31, 2009 | $1.12B | +7.6% |
| FY2008 | Dec 31, 2008 | $1.04B | -4.3% |
| FY2007 | Dec 31, 2007 | $1.08B | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $447.80M | +18.4% |
| Q1 FY2026 | Mar 31, 2026 | $359.40M | -6.1% |
| Q4 FY2025 | Dec 31, 2025 | $517.40M | +2.2% |
| Q3 FY2025 | Sep 30, 2025 | $418.70M | +5.8% |
| Q2 FY2025 | Jun 30, 2025 | $378.20M | +2.4% |
| Q1 FY2025 | Mar 31, 2025 | $382.80M | +67.9% |
| Q4 FY2024 | Dec 31, 2024 | $506.30M | -14.0% |
| Q3 FY2024 | Sep 30, 2024 | $395.70M | +17.2% |
| Q2 FY2024 | Jun 30, 2024 | $369.40M | +6.2% |
| Q1 FY2024 | Mar 31, 2024 | $228.00M | -25.9% |
| Q4 FY2023 | Dec 31, 2023 | $588.40M | +141.0% |
| Q3 FY2023 | Sep 30, 2023 | $337.60M | -25.1% |
| Q2 FY2023 | Jun 30, 2023 | $347.90M | +0.7% |
| Q1 FY2023 | Mar 31, 2023 | $307.70M | -2.5% |
| Q4 FY2022 | Dec 31, 2022 | $244.20M | -27.7% |
| Q3 FY2022 | Sep 30, 2022 | $450.80M | +6.3% |
| Q2 FY2022 | Jun 30, 2022 | $345.50M | -17.5% |
| Q1 FY2022 | Mar 31, 2022 | $315.70M | +41.3% |
| Q4 FY2021 | Dec 31, 2021 | $337.60M | +14.0% |
| Q3 FY2021 | Sep 30, 2021 | $424.20M | +11.3% |
| Q2 FY2021 | Jun 30, 2021 | $419.00M | – |
| Q1 FY2021 | Mar 31, 2021 | $223.50M | -50.4% |
| Q4 FY2020 | Dec 31, 2020 | $296.20M | -30.0% |
| Q3 FY2020 | Sep 30, 2020 | $381.30M | -34.0% |
| Q2 FY2020 | Jun 30, 2020 | -$52.80M | -117.5% |
| Q1 FY2020 | Mar 31, 2020 | $450.90M | +59.0% |
| Q4 FY2019 | Dec 31, 2019 | $423.30M | +11.5% |
| Q3 FY2019 | Sep 30, 2019 | $577.90M | +19.4% |
| Q2 FY2019 | Jun 30, 2019 | $301.00M | -23.5% |
| Q1 FY2019 | Mar 31, 2019 | $283.60M | -42.2% |
| Q4 FY2018 | Dec 31, 2018 | $379.50M | -5.8% |
| Q3 FY2018 | Sep 30, 2018 | $484.10M | +4.4% |
| Q2 FY2018 | Jun 30, 2018 | $393.30M | -10.7% |
| Q1 FY2018 | Mar 31, 2018 | $490.50M | +78.1% |
| Q4 FY2017 | Dec 31, 2017 | $402.90M | -35.8% |
| Q3 FY2017 | Sep 30, 2017 | $463.50M | +31.5% |
| Q2 FY2017 | Jun 30, 2017 | $440.50M | – |
| Q1 FY2017 | Mar 31, 2017 | $275.40M | – |
| Q4 FY2016 | Dec 31, 2016 | $627.20M | – |
| Q3 FY2016 | Sep 30, 2016 | $352.60M | – |
See a number that looks wrong?